3Chopt Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.81M Buy
4,014
+385
+11% +$393K 0.9% 24
2026
Q1
$3.34M Buy
3,629
+31
+0.9% +$31.4K 0.76% 26
2025
Q4
$3.87M Sell
3,598
-1,349
-27% -$1.29M 0.87% 23
2025
Q3
$3.77M Buy
4,947
+1,399
+39% +$1.04M 0.86% 25
2025
Q2
$2.77M Sell
3,548
-819
-19% -$636K 0.67% 36
2025
Q1
$3.61M Sell
4,367
-565
-11% -$470K 0.94% 22
2024
Q4
$3.81M Sell
4,932
-146
-3% -$121K 1.31% 15
2024
Q3
$4.5M Buy
5,078
+1,332
+36% +$1.2M 1.61% 11
2024
Q2
$3.39M Buy
3,746
+483
+15% +$386K 1.04% 19
2024
Q1
$2.54M Sell
3,263
-214
-6% -$152K 1.04% 34
2023
Q4
$2.03M Buy
+3,477
New +$2.03M 0.75% 42
2023
Q3
Sell
-2,348
Closed -$1.1M 98
2023
Q2
$1.1M Hold
2,348
0.55% 52
2023
Q1
$806K Buy
2,348
+600
+34% +$202K 0.43% 67
2022
Q4
$639K Buy
+1,748
New +$620K 0.35% 68

Other funds holding LLY

3Chopt Investment Partners's LLY Position: Q2 2026 in Review

3Chopt Investment Partners increased its Eli Lilly (LLY) stake by 11% in Q2 2026, buying an estimated $393K and bringing the position to 4,014 shares worth $4.81M. The position accounts for 0.9% of the portfolio, ranked #24.

3Chopt Investment Partners first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 3Chopt Investment Partners held 4,014 shares of Eli Lilly worth $4.81M as of Q2 2026.
  • 3Chopt Investment Partners bought 385 Eli Lilly shares in Q2 2026, an estimated $393K.
  • Eli Lilly made up 0.9% of 3Chopt Investment Partners's portfolio in Q2 2026, its #24 holding.
  • 3Chopt Investment Partners first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.